Renovaro Biosciences (RENB) - 2022 Q4 - Annual Report

Commission file number 000-54478 For the fiscal year ended June 30, 2022 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ENOCHIAN BIOSCIENCES INC. (Name of registrant in its charter) | Delaware | 45-2559340 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | | i ...